PGAP3
GPI-specific phospholipase A2-like PGAP3
Also known as: CAB2, MGC9753, PER1, PERLD1, PGAP3_HUMAN, PP1498
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96FM1
- Gene
- PGAP3
- Ensembl
- ENSG00000161395
- Chromosome
- 17
- Canonical length
- 320 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Plasma membrane,Cytosol
OverviewNCBI Gene
This gene encodes a glycosylphosphatidylinositol (GPI)-specific phospholipase that primarily localizes to the Golgi apparatus. This ubiquitously expressed gene is predicted to encode a seven-transmembrane protein that removes unsaturated fatty acids from the sn-2 position of GPI. The remodeling of the constituent fatty acids on GPI is thought to be important for the proper association between GPI-anchored proteins and lipid rafts. The tethering of proteins to plasma membranes via posttranslational GPI-anchoring is thought to play a role in protein sorting and trafficking. Mutations in this gene cause an autosomal recessive form of neurologic hyperphosphatasia with cognitive disability (HPMRS4). Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2017]
Canonical amino-acid sequenceUniProt
320 residues, UniProt reviewed canonical sequence.
>Q96FM1|PGAP3
1 MAGLAARLVL LAGAAALASG SQGDREPVYR DCVLQCEEQN CSGGALNHFR SRQPIYMSLA
61 GWTCRDDCKY ECMWVTVGLY LQEGHKVPQF HGKWPFSRFL FFQEPASAVA SFLNGLASLV
121 MLCRYRTFVP ASSPMYHTCV AFAWVSLNAW FWSTVFHTRD TDLTEKMDYF CASTVILHSI
181 YLCCVRTVGL QHPAVVSAFR ALLLLMLTVH VSYLSLIRFD YGYNLVANVA IGLVNVVWWL
241 AWCLWNQRRL PHVRKCVVVV LLLQGLSLLE LLDFPPLFWV LDAHAIWHIS TIPVHVLFFS
301 FLEDDSLYLL KESEDKFKLDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PGAP3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 35 nTPM
Expression across tissuesHPA
Tissue
- liver: 35 nTPM
- pancreas: 26 nTPM
- thyroid gland: 26 nTPM
- esophagus: 25 nTPM
- salivary gland: 24 nTPM
- parathyroid gland: 21 nTPM
Single-cell type
- esophageal apical cells: 50 nCPM
- lacrimal acinar cells: 27 nCPM
- colonocytes: 23 nCPM
- rod photoreceptor cells: 23 nCPM
- retinal horizontal cells: 22 nCPM
- renal collecting duct intercalated cells: 22 nCPM
Immune cell
- gdT-cell: 15 nTPM
- memory CD8 T-cell: 13 nTPM
- intermediate monocyte: 12 nTPM
- memory CD4 T-cell: 11 nTPM
- NK-cell: 10 nTPM
- naive CD4 T-cell: 10 nTPM
Brain region
- cerebral cortex: 16 nTPM
- amygdala: 15 nTPM
- hypothalamus: 14 nTPM
- basal ganglia: 14 nTPM
- hippocampal formation: 14 nTPM
- choroid plexus: 13 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PGAP3.
Disease | AllUniProt
Conditions PGAP3 is implicated in, by any mechanism.
- Hyperphosphatasia with impaired intellectual development syndrome 4 (HPMRS4) MIM:615716
Disease | GeneticClinVar
40 pathogenic / likely-pathogenic of 249 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Hyperphosphatasia with intellectual disability syndrome 4
- Inborn genetic diseases
- PGAP3-related disorder
- Hyperphosphatasia-intellectual disability syndrome
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.83
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.69
- DepMap mean gene effect
- -0.15
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- acting on ester bonds
- hydrolase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Per1-like
- Per1-like family
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PGAP3 as an antibody target. Whether an autoantibody or antibody against PGAP3 could matter depends on whether native PGAP3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PGAP3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PGAP3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...